STAAR Surgical Company (NASDAQ:STAA) will hold its 3Q20 earnings conference call with the financial community on 4th November 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.staar.com
Earnings Expectation
STAAR Surgical Company manufacturer of eye care devices, is reporting third quarter earnings results on Wednesday 4th November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.03 per share from $ 42.99 million in revenue. For the full year, analysts predict revenues of $ 156.24 million, while looking forward to income of $ 0.05 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 177.20 million ~ $ 177.20 million
Click Here For More Historical Outlooks Of STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery.
